Schizophrenia literally means “split mind,” derived from the Greek words schizein (to split) and phren (mind). But this name is widely misunderstood. It does not refer to a “split personality” or switching between different identities. The “splitting” that psychiatrist Eugen Bleuler described when he coined the term in 1908 was about a fragmentation of mental functions: thoughts disconnecting from emotions, perceptions drifting away from reality, motivation breaking apart from action. Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and perceives the world, and it impacts roughly 1 in 300 people globally.
Where the Name Comes From
Before the word “schizophrenia” existed, the condition was called dementia praecox, Latin for “early dementia.” Bleuler argued that this older name was wrong on both counts: the condition wasn’t dementia, and it didn’t always appear early in life. On April 24, 1908, at a meeting of the German Psychiatric Association in Berlin, he proposed the new term to highlight what he saw as the illness’s defining feature. As he wrote in 1911: “I call dementia praecox schizophrenia because the splitting of the different psychic functions is one of its most important features. As the disease becomes distinct, the personality loses its unity.”
Unfortunately, “split mind” has caused over a century of confusion. Many people assume schizophrenia means having multiple personalities, which is actually a separate condition called dissociative identity disorder. The two are classified as entirely distinct diagnostic categories. People with dissociative identity disorder tend to experience depersonalization and identity fragmentation, often linked to trauma. People with schizophrenia primarily experience breaks from shared reality: hearing things others don’t hear, holding beliefs that aren’t grounded in evidence, or losing motivation and emotional expressiveness.
What Schizophrenia Actually Looks Like
The symptoms of schizophrenia fall into two broad groups, often called positive and negative symptoms. “Positive” doesn’t mean good. It means something is added to a person’s experience that wasn’t there before. “Negative” means something is taken away.
Positive Symptoms
These are the features most people associate with the disorder. Delusions are fixed false beliefs: a person might become convinced they’re being watched, that they have special powers, or that a catastrophe is imminent. Most people with schizophrenia experience delusions at some point. Hallucinations involve perceiving things that aren’t there. They can affect any sense, but hearing voices is by far the most common form. These voices feel completely real to the person experiencing them. Disorganized speech is another hallmark, where a person’s sentences may jump between unrelated topics or become incoherent, reflecting a breakdown in organized thinking.
Negative Symptoms
These tend to be less dramatic but often more disabling over time. They include blunted affect (reduced facial expressions, flat tone of voice, fewer hand gestures), poverty of speech (saying very little, even when prompted), social withdrawal, loss of motivation to start or finish activities, and an inability to experience pleasure from things that used to be enjoyable. A person with prominent negative symptoms might stop maintaining friendships, lose interest in hobbies, struggle to keep up with work or school, and appear emotionally “flat” to the people around them. These symptoms are frequently mistaken for laziness or depression, which can delay getting the right help.
Early Warning Signs
Schizophrenia rarely appears overnight. The first full psychotic episode is typically preceded by a prodromal phase that can last weeks, months, or even years. During this period, a person may experience depression, anxiety, sleep disruption, difficulty concentrating, social isolation, or declining performance at school or work. These early signs are nonspecific, meaning they overlap with many other conditions, which makes them easy to dismiss.
Closer to the onset of psychosis, more distinctive changes tend to emerge. A person might have unusual thoughts they can still question (“I feel like people are talking about me, but maybe not”), brief perceptual disturbances (hearing a faint voice occasionally, seeing something flicker at the edge of vision), or subtle shifts in how they use language. These attenuated symptoms typically occur infrequently, perhaps once or twice a month, last only minutes, and the person can usually still be talked through them. As the illness progresses, these experiences intensify and become more persistent. Most people who develop schizophrenia are adolescents or young adults when these early changes begin.
What Happens in the Brain
The leading explanation centers on dopamine, a chemical messenger involved in motivation, reward, and how the brain filters incoming information. In schizophrenia, dopamine signaling appears to be overactive in deeper brain regions responsible for emotion and reward, which is thought to drive hallucinations and delusions. At the same time, dopamine signaling is underactive in the prefrontal cortex, the area behind your forehead that handles planning, decision-making, and social behavior. This deficit likely contributes to the negative symptoms and cognitive difficulties.
Other chemical messenger systems are involved too, including those that regulate how brain cells communicate with each other and how signals get amplified or dampened. Brain imaging studies have found measurable differences in dopamine levels in the prefrontal cortex and hippocampus (a region critical for memory) between people with schizophrenia and those without. The picture is complex. Schizophrenia is not simply “too much” or “too little” of one chemical. It’s a pattern of imbalances across multiple systems and brain regions.
Causes and Risk Factors
Genetics play a substantial role. A large Danish twin study estimated the heritability of schizophrenia at 79%, meaning that roughly four-fifths of the variation in who develops the disorder can be attributed to genetic factors. But heritability is not destiny. Having an identical twin with schizophrenia gives you roughly a 50% chance of developing it yourself, not 100%. The remaining risk comes from environmental factors: complications during pregnancy or birth, childhood adversity, growing up in an urban environment, cannabis use during adolescence, and high levels of stress.
No single gene causes schizophrenia. Hundreds of genetic variants each contribute a small amount of risk. This is why the disorder runs in families without following a simple inheritance pattern. A person can carry significant genetic risk and never develop the condition, while someone with modest genetic risk may develop it after encountering the right combination of environmental triggers.
Treatment and Long-Term Outlook
Schizophrenia is treatable, and the long-term outlook is more hopeful than many people assume. Medications that reduce dopamine activity in overactive brain regions are the first line of treatment and are effective at controlling hallucinations and delusions for most people. Negative symptoms and cognitive difficulties are harder to treat with medication alone, which is why psychological therapies, social skills training, and supported employment programs are important parts of a comprehensive approach.
A 10-year follow-up study of people after their first episode found that 50% met criteria for clinical recovery, defined as at least two years of minimal symptoms combined with meaningful real-world functioning: holding at least part-time work or attending school, living independently, and maintaining social relationships. This doesn’t mean the other half are severely impaired. Many achieve partial recovery, with periods of stability and periods of relapse. Early treatment after the first episode consistently predicts better outcomes.
The World Health Organization estimates that schizophrenia affects approximately 23 million people worldwide. Among adults specifically, the rate is about 1 in 233. It occurs across every culture, income level, and geographic region, though access to treatment varies enormously.